OQS
PDSB icon

Occudo Quantitative Strategies’s PDS Biotechnology PDSB Stock Holding History

Occudo Quantitative Strategies’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-24,369
Closed -$123K – 1100
2023
Q3 		$123K Sell
24,369
-16,091
-40% -$88.1K 0.02% 855
2023
Q2 		$204K Buy
+40,460
New +$265K 0.02% 844
2022
Q4 		– Sell
-22,496
Closed -$67K – 1270
2022
Q3 		$67K Buy
22,496
+411
+2% +$1.74K 0.01% 1072
2022
Q2 		$81K Buy
+22,085
New +$105K 0.01% 1034

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Occudo Quantitative Strategies's PDSB Position: Q4 2023 in Review

Occudo Quantitative Strategies sold out of PDS Biotechnology (PDSB) in Q4 2023, closing a stake of 24,369 shares — an estimated $123K sold.

Occudo Quantitative Strategies first reported a position in PDSB in Q2 2022 and held it in 4 quarters. The position peaked at $204K in Q2 2023. 77 funds tracked by Wall St. Rank hold PDSB as of Q4 2023.

  • Occudo Quantitative Strategies reported no remaining PDS Biotechnology position as of Q4 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 24,369 PDS Biotechnology shares in Q4 2023, an estimated $123K.
  • Occudo Quantitative Strategies first reported a position in PDS Biotechnology in Q2 2022 and held it in 4 quarters.
  • Occudo Quantitative Strategies's PDS Biotechnology position peaked at $204K in Q2 2023.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.